CLINICAL_TRIALS
trial_result
· 2014-08-21
Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of Tacrolimus in Korean Nephropathy Patients [Phase 2]
Summary
A Phase 2 trial evaluating the efficacy and safety of tacrolimus in IgA nephropathy in Korean patients has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Astellas Pharma Inc | Conditions: IgA Nephropathy | Phase 2 | Status: COMPLETED